<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01437124</url>
  </required_header>
  <id_info>
    <org_study_id>960558216</org_study_id>
    <nct_id>NCT01437124</nct_id>
  </id_info>
  <brief_title>Metal Ions in Ceramic on Metal Total Hip Arthroplasty</brief_title>
  <acronym>COM</acronym>
  <official_title>Measurement of Metal Ion Levels and Chromosome Abnormalities in Ceramic on Metal Total Hip Arthroplasty in Vivo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hussain Kazi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wirral University Teaching Hospital NHS Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to measure the blood levels of certain metals in a group of patients
      all of whom have had a ceramic on metal total hip replacement. This new bearing surface
      (joint) is relatively new and the investigators are currently following up the largest cohort
      in the world. Clinical results are currently excellent at 2 years in all patients, however
      the investigators are mindful of the lessons learned from the high failure rate of several
      designs of metal on metal hip replacements as well as several in vitro reports and one in
      vivo case report of elevated metal levels in this particular implant. The investigators feel
      it is important to measure the metal ion levels in our group to ascertain and compare these
      with reference standards. Once performed the investigators can relate ion levels to function
      and x ray changes and provide useful longterm data to the patients and the wider medical
      community as to whether this bearing surface is safe in the long term or whether it's use
      should be abandoned. This is useful as there are numerous groups implanting this device in
      the UK and in addition it has just been awarded FDA approval in the USA - its use is likely
      to flourish.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PURPOSE &amp; DESIGN:

      The investigators are currently following up a cohort of patients all of whom have had a
      metal on ceramic total hip arthroplasty.

      This new bearing couple has been approved for use in the UK for some time and has recently
      achieved USA FDA approval.

      The attraction of this bearing couple is a low rate of wear with reduced complications
      associated with ceramic on ceramic bearing such as bearing fracture.

      Of recent media attention has been the unacceptably high failure of the DePuy ASR metal on
      metal hip resurfacing. This metal on metal bearing couple has been associated with increased
      ion levels and chromosome abnormalities in vivo.

      In vitro studies and small in vivo studies have revealed much lower wear, particle numbers
      and ion levels in ceramic on metal studies than in metal on metal bearing surfaces; however
      there is no large scale evidence that this is the case.

      The investigators currently are following up the largest worldwide series of ceramic on metal
      bearings and clinical results are excellent. It is important however to obtain hard data on
      metal ion levels in this population firstly to ensure the long term function and health of
      this cohort but also to provide a barometer for other surgeons who will be using a prosthesis
      that as yet has little in the way of long term follow up and data on ion levels in a large
      cohort.

      If the ion levels are unacceptably high then the investigators will need to follow these
      patients closely and offer revision surgery if there are clinical concerns.

      For similar reasons it is important to monitor for chromosomal abnormalities.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Cobalt Chromium Levels</measure>
    <time_frame>2 years post THR</time_frame>
    <description>Serum cobalt chromium levels post THR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chromosomal Abnormality</measure>
    <time_frame>2 years post THR</time_frame>
    <description>Deviation of karyotype from normal 2 years post THR</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">83</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Avascular Necrosis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Developmental Dysplasia of the Hip</condition>
  <arm_group>
    <arm_group_label>Ceramic on metal THA</arm_group_label>
    <description>Those who have received a ceramic on metal total hip replacement</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Those who have received a ceramic on metal total hip arthroplasty
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age

          -  Complete history and physical examination

          -  Previously performed ceramic on metal total hip replacement

          -  An understanding of the purpose of the study and signed consent form

        Exclusion Criteria:

          -  Hip arthroplasty other than ceramic on metal bearing

          -  Mentally infirm / incapacitated

          -  Incomplete history or physical examination

          -  Unwillingness to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fintan A Carroll, MBBS, FRCS</last_name>
    <role>Study Director</role>
    <affiliation>Consultant Orthopaedic Surgeon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hussain A Kazi, MBChB,FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Specialist Registrar, Trauma &amp; Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wirral University Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Wirral</city>
        <state>Merseyside</state>
        <zip>CH49 5PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2011</study_first_submitted>
  <study_first_submitted_qc>September 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2011</study_first_posted>
  <results_first_submitted>April 27, 2016</results_first_submitted>
  <results_first_submitted_qc>April 27, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 6, 2016</results_first_posted>
  <last_update_submitted>April 27, 2016</last_update_submitted>
  <last_update_submitted_qc>April 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wirral University Teaching Hospital NHS Trust</investigator_affiliation>
    <investigator_full_name>Hussain Kazi</investigator_full_name>
    <investigator_title>Specialist Registrar, Trauma and Orthopaedics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Hip Dislocation, Congenital</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ceramic on Metal THA</title>
          <description>Those who have received a ceramic on metal total hip replacement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ceramic on Metal THA</title>
          <description>Those who have received a ceramic on metal total hip replacement</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="83"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" lower_limit="42" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cobalt Chromium Levels</title>
        <description>Serum cobalt chromium levels post THR</description>
        <time_frame>2 years post THR</time_frame>
        <population>metal ion levels</population>
        <group_list>
          <group group_id="O1">
            <title>Ceramic on Metal THA</title>
            <description>Those who have received a ceramic on metal total hip replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Cobalt Chromium Levels</title>
          <description>Serum cobalt chromium levels post THR</description>
          <population>metal ion levels</population>
          <units>micrograms/dl</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" lower_limit="0.05" upper_limit="7.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chromosomal Abnormality</title>
        <description>Deviation of karyotype from normal 2 years post THR</description>
        <time_frame>2 years post THR</time_frame>
        <population>24 colour FISH</population>
        <group_list>
          <group group_id="O1">
            <title>Ceramic on Metal THA</title>
            <description>Those who have received a ceramic on metal total hip replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Chromosomal Abnormality</title>
          <description>Deviation of karyotype from normal 2 years post THR</description>
          <population>24 colour FISH</population>
          <units>% chromosomal abberations</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" lower_limit="0" upper_limit="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ceramic on Metal THA</title>
          <description>Those who have received a ceramic on metal total hip replacement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hussain Kazi</name_or_title>
      <organization>Wirral NHS Trust</organization>
      <phone>0151 678 6111</phone>
      <email>hussainkazi@nhs.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

